Integra LifeSciences | IART - Selling And Administration Expenses


Integra LifeSciences reported $161.02M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
AtriCure USD 82.56M 1.99M Jun/2026
Baxter International USD 735M 7M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Boston Scientific USD 1.8B 22M Jun/2026
CONMED USD 145.55M 3.85M Jun/2026
Cooper Companies USD 401.3M 274.9M Jun/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
Globus Medical USD 286.82M 10.95M Jun/2026
HeartBeam USD 1.18M 96.62K Dec/2025
Insulet USD 344.8M 27.6M Jun/2026
Integra LifeSciences USD 161.02M 5.2M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
J&J USD 6.25B 168M Sep/2026
Medtronic 3.2B 141M Jun/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Orthofix International USD 130.35M 11.31M Dec/2025
Smith & Nephew USD 1.45B 29M Jun/2026
Stryker USD 2.12B 32M Jun/2026
Tandem Diabetes Care USD 111.64M 3.45M Jun/2026
Teleflex USD 213.52M 12.5M Jun/2026
Zimmer Biomet Holdings USD 911.6M 61.7M Jun/2026